| Product Code: ETC7279545 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia Cannabis Pharmaceutical Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Georgia Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Georgia Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Georgia Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance and legalization of medical cannabis in Georgia |
4.2.2 Growing awareness and demand for alternative healthcare solutions |
4.2.3 Rising investments and collaborations in the cannabis pharmaceutical industry |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on cannabis cultivation and distribution in Georgia |
4.3.2 Limited availability of medical professionals trained in cannabis-based treatments |
5 Georgia Cannabis Pharmaceutical Market Trends |
6 Georgia Cannabis Pharmaceutical Market, By Types |
6.1 Georgia Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Georgia Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Georgia Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Georgia Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Georgia Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Georgia Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Georgia Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Georgia Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Georgia Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Georgia Cannabis Pharmaceutical Market Imports from Major Countries |
8 Georgia Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of medical cannabis patients registered in Georgia |
8.2 Research and development investment in cannabis pharmaceuticals |
8.3 Number of clinical trials conducted on cannabis-based treatments |
8.4 Percentage of healthcare providers educated on cannabis medicine |
8.5 Patient satisfaction and reported health outcomes with cannabis pharmaceuticals |
9 Georgia Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Georgia Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Georgia Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Georgia Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Georgia Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here